82VS
82VS is our affiliated venture studio that pairs Alloy’s platforms and services with a team of company creation experts to efficiently launch new asset-centric…
FemHealth Ventures
As part of our investment approach, we developed a structured evaluation process, the “FemHealth Framework.” The first element (re)imagines women’s health as co…
Forbion
Forbion is a leading European venture capital firm that helps companies bridge research and development through the team’s expertise in drug development and com…
Adjuvant Capital
We see enormous opportunity in historically overlooked market segments, and we leverage our unique expertise to translate these opportunities into social and fi…
Omega Funds
Omega Funds is a leading international investment firm that creates and invests in life sciences companies that target the world’s most urgent medical needs. Ω…
Mirae Asset Capital Life Science
Mirae Asset Capital Life Science was formed in 2023 as a joint venture between Mirae Asset Capital and Mirae Asset Global Investments. It is the first and only…
Claris Ventures
Claris Ventures SGR is a venture capital firm based in Italy, founded in 2019. Its first fund under management, Claris Biotech I, is focused on early stage inve…
Pfizer Ventures
With a $600M capital commitment for investment, Pfizer Ventures backs private companies at all stages of development. We have a strong focus on early-stage oppo…
FORM Life Ventures
We invest to keep people healthy. We invest in companies to drive the shift from traditional sickcare to modern healthcare. People are not destined to become s…
Aditum Bio
Aditum Bio brings together unmatched scientific and domain expertise with agile operational capabilities. Our unique investment and operating model enables rapi…
Takeda Ventures
We invest in early-stage opportunities that complement Takeda’s pipeline and products. Our mission is to create strategic growth opportunities for Takeda by inv…
Apollo Health Ventures
Apollo Health Ventures is a transatlantic early stage Venture Capital firm actively co-founding and investing in transformative healthcare companies targeting a…
Cystic Fibrosis Foundation
We are the global leader in the search for a cure for cystic fibrosis and nearly every CF drug and therapy available today was made possible because of CF Found…
Sofinnova Investments
We are a healthcare investment firm with approximately $3.0B in assets under management and committed capital. We invest in both private and public equity compa…
KP Rx
Established in 2023, KP Rx is a 100% founder-owned investment firm specialising in private and early-stage public healthcare investments in Australia and New Ze…
SymBiosis
We invest in groundbreaking medicines across disease area, financing stage, and geography, with a focus on programs in, or about to enter, human trials. We are…
Droia Ventures
Droia invests in novel science and innovative approaches to bring promising drug candidates to patients, and accelerate their progress by actively supporting yo…
Pappas Capital
At Pappas Capital, we are dedicated to furthering life science discoveries and bringing groundbreaking solutions to market. Pappas Capital is laser focused on t…
15th Rock Ventures
How many of us will enjoy a healthy lifespan of over 100 years old in the coming era of longevity? Why must people with disabilities have life limitations? Huma…
T1D Fund
The T1D Fund invests in areas strategically aligned with JDRF, with an emphasis on cure-oriented or disease modifying therapies. The T1D Fund is an evergreen mo…